Activity of ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa

被引：0
|
作者：
Wi, Y. M. [1 ]
Greenwood-Quaintance, K. E. [9 ]
Ko, K. S. [2 ]
Kwon, K. T. [3 ]
Jung, S. -I. [4 ]
Kim, Y. -S. [5 ]
Kim, S. -W. [6 ]
Yeom, J. -S. [7 ]
Peck, K. R. [8 ]
Song, J. -H. [8 ]
Patel, R. [9 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Seoul, South Korea
[3] Daegu Patima Hosp, Div Infect Dis, Daegu, South Korea
[4] Chonnam Natl Univ Hosp, Div Infect Dis, Gwangju, South Korea
[5] Chungnam Natl Univ, Sch Med, Div Infect Dis, Gwangju, South Korea
[6] Kyungpook Natl Univ, Sch Med, Div Infect Dis, Daegu, South Korea
[7] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Infect Dis, Sch Med, Seoul, South Korea
[8] Sungkyunkwan Univ, Samsung Med Ctr, Div Infect Dis, Sch Med, Seoul, South Korea
[9] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN USA
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P2-AG08
引用
收藏
页码：S124 / S125
页数：2
相关论文
共 50 条
  • [1] Susceptibility of ceftolozane/tazobactam against multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa
    Kakehi, Ayaka
    Hagiya, Hideharu
    Iio, Koji
    Fujimori, Takumi
    Okura, Mami
    Minabe, Hiroshi
    Yokoyama, Yukika
    Otsuka, Fumio
    Higashikage, Akihito
    [J]. NEW MICROBIOLOGICA, 2023, 46 (02): : 213 - 215
  • [2] Satisfactory In Vitro Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant Pseudomonas aeruginosa But Not against Klebsiella pneumoniae Isolates
    Sekowska, Alicja
    Grabowska, Marta
    Bogiel, Tomasz
    [J]. MEDICINA-LITHUANIA, 2023, 59 (03):
  • [3] Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa
    Lopez-Cerero, Lorena
    Ballesta, Sofia
    Lopez, Cristina Elias
    Sanchez-Yebra, Waldo
    Rojo-Martin, Maria Dolores
    Pascual, Alvaro
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (10): : 621 - 624
  • [4] Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa
    Munita, Jose M.
    Aitken, Samuel L.
    Miller, William R.
    Perez, Federico
    Rosa, Rossana
    Shimose, Luis A.
    Lichtenberger, Paola N.
    Abbo, Lilian M.
    Jain, Rupali
    Nigo, Masayuki
    Wanger, Audrey
    Araos, Rafael
    Tran, Truc T.
    Adachi, Javier
    Rakita, Robert
    Shelburne, Samuel
    Bonomo, Robert A.
    Arias, Cesar A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) : 158 - 161
  • [5] Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany
    Kresken, Michael
    Koerber-Irrgang, Barbara
    Korte-Berwanger, Miriam
    Pfennigwerth, Niels
    Gatermann, Soeren G.
    Seifert, Harald
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (06)
  • [6] Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales
    Bail, Larissa
    Sanches Ito, Carmen Antonia
    Villa Stangler Arend, Lavinia Nery
    Nogueira, Keite da Silva
    Tuon, Felipe Francisco
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 102 (01)
  • [7] Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms
    Wi, Yu Mi
    Greenwood-Quaintance, Kerryl E.
    Schuetz, Audrey N.
    Ko, Kwan Soo
    Peck, Kyong Ran
    Song, Jae-Hoon
    Patel, Robin
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [8] Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa
    Nasomsong, Worapong
    Nulsopapon, Parnrada
    Changpradub, Dhitiwat
    Pungcharoenkijkul, Supanun
    Hanyanunt, Patomroek
    Chatreewattanakul, Tassanawan
    Santimaleeworagun, Wichai
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (04):
  • [9] Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa
    Gill, Christian M.
    Nicolau, David P.
    RACE PA Global Study Grp
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (01) : 252 - 256
  • [10] Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
    Shields, Ryan K.
    Clancy, Cornelius J.
    Pasculle, A. William
    Press, Ellen G.
    Haidar, Ghady
    Hao, Binghua
    Chen, Liang
    Kreiswirth, Barry N.
    Nguyen, M. Hong
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (02)
12345